Pharmacology of Insulin Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Describe the actions of insulin

A
  • Increase glucose transport into adipose tissue and skeletal muscle
  • Increase glycogenesis and decrease glycogenolysis in liver and muscle
  • Increase lipogenesis and decrease lipolysis in adipose tissue
  • Decrease ketogenesis in liver
  • Increase amino acid uptake and protein synthesis in liver, muscle and adipose tissue
  • Decrease proteolysis in liver, muscle and adipose tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the mechanism of action of insulin

A
  • Insulin binds to target cells through insulin receptor (tyrosine kinase)
  • Stimulates insertion of glucose transporter (GLUT-4) onto target cell membrane of skeletal muscle or adipose tissue
  • Glucose moves from plasma inside the cell
  • When insulin binds to liver, stimulates glycogen synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the actions of glucagon

A
  • Increase glycogenolysis and decrease glycogenesis in liver
  • Increase gluconeogenesis in liver (synthesize glucose from amino acids)
  • Increase ketogenesis in liver
  • Increase lipolysis in adipose tissue
  • Stimulated in high amino acid in starvation - digestion of muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the mechanism of action of glucagon

A
  • Glucagon binds to GPCR receptors which activate adenylyl cyclase
  • Increases cyclic AMP which activates protein kinase A
  • Phosphorylates and thereby activates important enzymes in target cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State the main categories of insulin analogues

A
  • Ultrafast acting
  • Rapid acting
  • Short acting
  • Intermediate acting
  • Long acting/very long acting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the action of ultrafast acting insulin analogue

A
  • Mimics normal insulin response after eating

- Eg. Aspart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the action of rapid acting insulin analogue

A
  • Rapid onset of action 5 to 15 minutes
  • Inject just before eating
  • Peaks at 60 min and lasts 4-6 hours
  • Eg. Humalog, Novorapid, Apidra
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the action of short-acting insulin analogue

A
  • Starts to work 30-60 minutes after injection
  • Need to inject at least 15-30 minutes before eating several times daily to cover meals
  • Peaks at 2-3 hours and lasts 8-10 hours
  • Eg. Actrapid, Humulin S, Hypurin Bovine and Porcine Neutral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the action of intermediate acting insulin analogue

A
  • Slower onset 2-4 hours
  • Peaks 4-8 hours and lasts 12 -20 hours - covers in-between meals and through night
  • Eg. Insulatard, Humulin I, Hypurin Bovine and Porcine Isophane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the action of long acting insulin analogue

A
  • Slow onset 2-6 hours
  • Duration up to 24 hours for long acting and 50+ hours for very long acting
  • Eg. Glargine, Detemir, Degludec
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe possible insulin regimes for type 1 diabetics

A
  • 4 injections - 3 rapid acting after each meal and 1 intermediate/long acting
  • 2 injections - 2 intermediate/long acting
  • 1 injection - 1 long acting
  • Regime depends on possibility of complications - a patient suffering from multiple macrovascular complications may have more injections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe how insulin pump therapy is used

A
  • Constant stream of rapid acting insulin when button is pressed
    • Used for type 1 diabetes after meals and when glucose levels high
  • Sensor augmented pump therapy with threshold suspend
    • Monitors glucose level in tissue and can switch on/off depending on levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are possible adverse effects of insulin therapy

A
  • Hypoglycaemia
  • Hyperglycaemia
  • Lipodystrophy - lipohypertrophy (lumps of fat) or lipoatrophy (death of fat cells)
  • Painful injections
  • Insulin allergies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the major oral hypoglycaemics used to treat diabetes

A
  • Metformin
  • Sulphonylureas
  • Acarbose
  • Glitazones
  • Glucagon like peptide 1
  • Gliptins / DPP-4 inhibitors
  • Dapagliflozin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the mechanism and effects of metformin

A
  • Decreases insulin resistance leading to increased glucose into tissues
  • Reduces hepatic gluconeogenesis
  • Limits weight gain
  • Decreases CVS events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List the main side effects of metformin

A
  • GI symptoms
  • Lactic acidosis - tiredness, weakness, muscle pain, trouble breathing
  • Hypoglycaemia - headache, weakness, confusion
  • Side effects more common in patients with organ failure - avoid giving to these patients
  • Stop if severe CKD
17
Q

Describe the action of sulphonylureas

A
  • Makes KATP more sensitive to ATP, so more insulin released
  • Eg. Gliclazide most used
18
Q

What are the main side effects of sulphonylureas

A
  • Weight gain
  • Hypoglycaemia - confusion, sweating, headache, dizziness
  • Hunger
19
Q

Describe the mechanism of action of acarbose

A
  • α glucoside inhibition
  • Inhibits breakdown of carbohydrates to glucose by blocking action of the enzyme α glucoside in gut
  • Decreased breakdown means less glucose absorbed
20
Q

What are the main side effects of acarbose

A
  • Flatulence
  • Loose stools
  • Diarrhoea
  • Stomach pain
  • Constipation
21
Q

Describe the mechanism of action of glitazones

A
  • Increase insulin sensitivity in muscle and adipose tissue and decrease hepatic gluconeogenesis
  • Bind to and activate one or more peroxisome proliferator-activated receptors (PPARs)
22
Q

What are the main side effects of glitazones

A
  • Weight gain
  • Fluid retention and heart failure
  • Effects on bone metabolism
  • Bladder cancer
23
Q

Describe the mechanism of action of glucagon like peptide 1

A
  • Increase insulin secretion from beta cells
  • Decreases production of glucagon from alpha cells
  • Decrease food intake through increased satiety - can help weight loss
  • Decrease gastric emptying
24
Q

What are the main side effects of glucagon like peptide 1

A
  • Nausea
  • GI symptoms - loose stools, diarrhoea
  • Gastro oesophageal reflux
  • Low risk of hypoglycaemia
  • Not given to CKD patients
25
Q

Describe the mechanism of action of gliptins or DPP-4 inhibitors

A
  • Inhibits DPP-4 activity increasing postprandial (after meal) active GLP-1 concentrations
  • Not as effective as giving GLP-1
26
Q

What are the main side effects of gliptins

A
  • GI symptoms
  • Pancreatitis
  • Low risk of hypoglycaemia
27
Q

Describe the mechanism of action of Dapagliflozin

A

Blocks glucose reabsorption in proximal convoluted tubule (SGLT2 inhibitors)

28
Q

What are the main side effects of Dapagliflozin

A
  • Increased risk of lower urinary tract symptoms - genital and UTI
  • Polyuria - osmotic diuresis (less sodium reabsorbed in PCT)
  • Hypoglycaemia
29
Q

Describe the management of type 1 diabetes

A
  • Non-pharmacological - increase exercise, reduce glucose diet, reduce weight
  • Subcutaneous insulin injections - life long
30
Q

Describe the stepwise management of type 2 diabetes

A
  • Non-pharmacological - increase exercise, reduce glucose diet, reduce weight
  • Initial treatment
    • Metformin
  • First intensification
    • Dual therapy with metformin and:
      • DPP-4, pioglitazone, sulphonylurea, glifoxins
  • Second intensification
    • Triple therapy with metformin, sulphonylurea and:
      • DPP-4, pioglitazone +/- glifoxins
    • Consider insulin therapy
  • Give hypertensive drugs if applicable - calcium channel blockers, ACE inhibitors